BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruff TA, Gertig DM, Otto BF, Gust ID, Sutanto A, Soewarso TI, Kandun N, Marschner IC, Maynard JE. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. J Infect Dis. 1995;171:290-296. [PMID: 7844364 DOI: 10.1093/infdis/171.2.290] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mast EE, Ward JW. Hepatitis B vaccines. Vaccines. Elsevier; 2008. pp. 205-41. [DOI: 10.1016/b978-1-4160-3611-1.50017-9] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
2 Muljono DH, Soemohardjo S. Hepatitis B Virus Molecular Diversity in Indonesia. In: Marzuki S, Verhoef J, Snippe H, editors. Tropical Diseases. Boston: Springer US; 2003. pp. 163-76. [DOI: 10.1007/978-1-4615-0059-9_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Mahoney FJ. Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection. Clin Microbiol Rev 1999;12:351-66. [DOI: 10.1128/cmr.12.2.351] [Cited by in Crossref: 228] [Cited by in F6Publishing: 66] [Article Influence: 9.9] [Reference Citation Analysis]
4 H Muljono D. Epidemiology of Hepatitis B and C in Republic of Indonesia. Euroasian J Hepatogastroenterol 2017;7:55-9. [PMID: 29201773 DOI: 10.5005/jp-journals-l0018-1212] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med. 2002;34:207-214. [PMID: 11817916 DOI: 10.1006/pmed.2001.0972] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
6 Wallace AS, Sobel H, Ryman TK, Mantaring JB 3rd, Silvestre M, Thorley M, Ducusin J, Nyunt-U S. Timing of hepatitis B vaccination and impact of non-simultaneous vaccination with DTP vaccine following introduction of a hepatitis B birth dose in the Philippines. J Public Health Policy 2012;33:368-81. [PMID: 22673757 DOI: 10.1057/jphp.2012.18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Patel MK, Le Calvez E, Wannemuehler K, Ségalin JM. Hepatitis B Vaccination Coverage and Prevalence of Hepatitis B Surface Antigen Among Children in French Polynesia, 2014. Am J Trop Med Hyg. 2016;94:1370-1375. [PMID: 27001757 DOI: 10.4269/ajtmh.15-0903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Karyana M, Kosasih H, Samaan G, Tjitra E, Aman AT, Alisjahbana B, Fatmawati, Gasem MH, Arif M, Sudarmono P, Suharto, Merati TP, Lane C, Siswanto, Siddiqui S. INA-RESPOND: a multi-centre clinical research network in Indonesia. Health Res Policy Syst 2015;13:34. [PMID: 26219280 DOI: 10.1186/s12961-015-0024-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I. An evaluation of emerging vaccines for childhood pneumococcal pneumonia. BMC Public Health 2011;11 Suppl 3:S26. [PMID: 21501444 DOI: 10.1186/1471-2458-11-S3-S26] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mahoney RT, Maynard JE. The introduction of new vaccines into developing countries. Vaccine 1999;17:646-52. [PMID: 10067669 DOI: 10.1016/s0264-410x(98)00246-1] [Cited by in Crossref: 80] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
11 Schweitzer A, Akmatov MK, Krause G. Hepatitis B vaccination timing: results from demographic health surveys in 47 countries. Bull World Health Organ 2017;95:199-209G. [PMID: 28250533 DOI: 10.2471/BLT.16.178822] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Upreti SR, Gurung S, Patel M, Dixit SM, Krause LK, Shakya G, Wannemuehler K, Rajbhandari R, Bohara R, Schluter WW. Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal. Vaccine 2014;32:4304-9. [PMID: 24951865 DOI: 10.1016/j.vaccine.2014.06.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
13 Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, Santosham M, Schmitt HJ. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008;86:140-6. [PMID: 18297169 DOI: 10.2471/blt.07.040089] [Cited by in Crossref: 460] [Cited by in F6Publishing: 247] [Article Influence: 32.9] [Reference Citation Analysis]
14 Fischer GW, Ottolini LCMG, Mond CJJ. Prospects for Vaccines During Pregnancy and in the Newborn Period. Clinics in Perinatology 1997;24:231-49. [DOI: 10.1016/s0095-5108(18)30194-5] [Cited by in Crossref: 28] [Article Influence: 1.1] [Reference Citation Analysis]
15 Wiesen E, Diorditsa S, Li X. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014. Vaccine. 2016;34:2855-2862. [PMID: 27020710 DOI: 10.1016/j.vaccine.2016.03.060] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
16 Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine 2007;25:5985-93. [PMID: 17604881 DOI: 10.1016/j.vaccine.2007.05.055] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
17 Khan M, Dong JJ, Acharya SK, Dhagwahdorj Y, Abbas Z, Jafri Sm W, Mulyono DH, Tozun N, Sarin SK. Hepatology issues in Asia: Perspectives from regional leaders. J Gastroenterol Hepatol 2004;19:S419-30. [DOI: 10.1111/j.1440-1746.2004.03728.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
18 Mao B, Patel MK, Hennessey K, Duncan RJ, Wannemuehler K, Soeung SC. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia. Vaccine 2013;31:4459-64. [PMID: 23684825 DOI: 10.1016/j.vaccine.2013.05.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
19 Hall C, Gibbons M, Murphy D, Nourse C. Prevalence of hepatitis B infection in women delivering at a community health centre in Dili, Timor-Leste and discussion of programmatic challenges. Trans R Soc Trop Med Hyg 2015;109:280-2. [PMID: 25582825 DOI: 10.1093/trstmh/tru207] [Reference Citation Analysis]
20 Darmawan E, Turyadi KE, Nursanty NK, Thedja MD, Muljono DH. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol. 2015;87:199-207. [PMID: 25521058 DOI: 10.1002/jmv.24045] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
21 Namgyal P. Impact of hepatitis B immunization, Europe and worldwide. Journal of Hepatology 2003;39:77-82. [DOI: 10.1016/s0168-8278(03)00269-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li X, Heffelfinger J, Wiesen E, Diorditsa S, Valiakolleri J, Nikuata AB, Nukuro E, Tabwaia B, Woodring J. Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education. Vaccine 2017;35:4396-401. [DOI: 10.1016/j.vaccine.2017.06.056] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
23 Otto BF, Suarnawa I, Stewart T, Nelson C, Ruff TA, Widjaya A, Maynard JE. At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain. Vaccine 1999;18:498-502. [DOI: 10.1016/s0264-410x(99)00242-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
24 Lin CC, Hsieh HS, Huang YJ, Huang YL, Ku MK, Hung HC. Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health. 2008;8:49. [PMID: 18254978 DOI: 10.1186/1471-2458-8-49] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
25 Ruff TA. Immunisation strategies for viral diseases in developing countries. Rev Med Virol 1999;9:121-38. [DOI: 10.1002/(sici)1099-1654(199904/06)9:2<121::aid-rmv240>3.0.co;2-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Vardas E, Mathai M, Blaauw D, Mcanerney J, Coppin A, Sim J. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 1999;58:111-5. [DOI: 10.1002/(sici)1096-9071(199906)58:2<111::aid-jmv2>3.0.co;2-b] [Cited by in Crossref: 40] [Article Influence: 1.7] [Reference Citation Analysis]
27 Chunsuttiwat S, Biggs B, Maynard J, Thamapalo S, Laoboripat S, Bovornsin S, Charanasri U, Pinyowiwat W, Kunasol P. Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand. Vaccine 1997;15:769-74. [DOI: 10.1016/s0264-410x(96)00226-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
28 van Hattum J, Boland GJ, Jansen KG, Kleinpenning AS, van Bommel T, van Loon AM, Abdurachman SA, Yusuf H, Rulos-van den Berg A, van den Berg J. Transmission profile of hepatitis B virus infection in the Batam region, Indonesia. Evidence for a predominantly horizontal transmission profile. Adv Exp Med Biol 2003;531:177-83. [PMID: 12916789 DOI: 10.1007/978-1-4615-0059-9_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut. 1996;38 Suppl 2:S18-S23. [PMID: 8786047 DOI: 10.1136/gut.38] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004; 10(3): 437-438 [PMID: 14760774 DOI: 10.3748/wjg.v10.i3.437] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 86] [Article Influence: 5.0] [Reference Citation Analysis]
31 Batey RG, Bollipo SJ. Hepatitis B. Drug Alcohol Rev 1996;15:289-305. [PMID: 16203384 DOI: 10.1080/09595239600186031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
32 Ie SI, Turyadi, Sidarta E, Sadhewa A, Purnomo GA, Soedarmono YS, Pattiiha MZ, Thedja MD, Harahap AR, Muljono DH. High Prevalence of Hepatitis B Virus Infection in Young Adults in Ternate, Eastern Indonesia. Am J Trop Med Hyg 2015;93:1349-55. [PMID: 26392157 DOI: 10.4269/ajtmh.15-0331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
33 Locarnini S, Hatzakis A, Chen DS, Lok A. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62:S76-S86. [PMID: 25920093 DOI: 10.1016/j.jhep.2015.01.018] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 20.0] [Reference Citation Analysis]
34 Cutts F, Hall A. Vaccines for neonatal viral infections: Hepatitis B vaccine. Expert Review of Vaccines 2014;3:349-52. [DOI: 10.1586/14760584.3.4.349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Fletcher MA, Fabre P, Debois H, Saliou P. Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature. International Journal of Infectious Diseases 2004;8:328-38. [DOI: 10.1016/j.ijid.2004.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
36 Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 1996;38 Suppl 2:S18-23. [PMID: 8786047 DOI: 10.1136/gut.38.suppl_2.s18] [Cited by in Crossref: 111] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
37 Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-816. [PMID: 19231008 DOI: 10.1016/j.jhep.2009.01.002] [Cited by in Crossref: 151] [Cited by in F6Publishing: 148] [Article Influence: 11.6] [Reference Citation Analysis]
38 Buttery JP, Graham SM. Immunisation timing: the protective layer in vaccine coverage. The Lancet 2009;373:1499-500. [DOI: 10.1016/s0140-6736(09)60340-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 Yano Y, Utsumi T, Lusida MI, Hayashi Y. Hepatitis B virus infection in Indonesia. World J Gastroenterol 2015; 21(38): 10714-10720 [PMID: 26478663 DOI: 10.3748/wjg.v21.i38.10714] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
40 de la Hoz F, Perez L, de Neira M, Hall AJ. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: Factors influencing hepatitis B virus infection and effectiveness. Int J Infect Dis. 2008;12:183-189. [PMID: 17913535 DOI: 10.1016/j.ijid.2007.06.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
41 Wilson N, Ruff TA, Rana BJ, Leydon J, Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine. 2000;18:3059-3066. [PMID: 10825610 DOI: 10.1016/s0264-410x(00)00080-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
42 Ruff TA, Taylor K, Nolan T. Australia's contribution to global immunisation. Aust N Z J Public Health 2012;36:564-9. [PMID: 23216498 DOI: 10.1111/j.1753-6405.2012.00956.x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
43 Purwono PB, Juniastuti, Amin M, Bramanthi R, Nursidah, Resi EM, Wahyuni RM, Yano Y, Soetjipto, Hotta H, Hayashi Y, Utsumi T, Lusida MI. Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant. Am J Trop Med Hyg 2016;95:674-9. [PMID: 27402524 DOI: 10.4269/ajtmh.15-0121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
44 Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine. 2004;22:2791-2799. [PMID: 15246613 DOI: 10.1016/j.vaccine.2004.01.046] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
45 Chen DS. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region. J Gastroenterol Hepatol 2000;15 Suppl:E7-10. [PMID: 10921374 DOI: 10.1046/j.1440-1746.2000.02095.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
46 Abushady EA, Gameel MM, Klena JD, Ahmed SF, Abdel-Wahab KS, Fahmy SM. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol 2011; 3(6): 147-156 [PMID: 21860674 DOI: 10.4254/wjh.v3.i6.147] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
47 Ortega-barrìa E, Kanra G, Leroux G, Bravo L, Safary A, Lefevre I. The immunogenicity and reactogenicity of DTPw-HBV/Hib 2.5 combination vaccine: Results from four phase III multicenter trials across three continents. Vaccine 2007;25:8432-40. [DOI: 10.1016/j.vaccine.2007.09.045] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
48 Lusida MI, Juniastuti, Yano Y. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol 2016; 22(32): 7264-7274 [PMID: 27621573 DOI: 10.3748/wjg.v22.i32.7264] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]